MedTrace Logo

DIMINI - Diabetes Mellitus? - Not me!

NCT03482674 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 530

Last updated 2018-04-06

No results posted yet for this study

Summary

The increasing prevalence of type 2 diabetes mellitus is a worldwide problem. In preventing risk factors and unhealthy lifestyle through improved health literacy, chances are seen to delay or even avoid type 2 diabetes mellitus. The aim of the DIMINI-project is to prevent type 2 diabetes mellitus and to strengthen the health literacy of people at increased risk of developing it. For this purpose, people at increased risk are first identified by using the standardized screening tool Finnish Diabetes Risk Score (FINDRISC) adapted for Germany. Identified risk persons then receive a needs-based, modular lifestyle intervention including nutrition tips and physical exercises either paper- or app-based.

Conditions

  • Health Behavior
  • Health Knowledge, Attitudes, Practice
  • Literacy
  • Diabetes Mellitus, Type 2
  • Diabetes

Interventions

BEHAVIORAL

DIMINI lifestyle intervention

DIMINI lifestyle intervention consists of the DIMINI-kit which contains health information, a list of food recommendations with additional information on calories, serving size and weight (traffic light rating system), a nutrition and an exercise diary. Participants in the intervention group can choose between a paper-based version or an app-based version of the DIMINI-kit. In addition, the kit includes an elastic exercise band with exercise poster, a measuring tape for self-control of the waist size and a pedometer.

Sponsors & Collaborators

  • Deutsche Diabetes Gesellschaft

    collaborator OTHER

  • Dimini Konsortium

    lead OTHER

Principal Investigators

  • Carsten Petersen, Dr. · docevent GmbH

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-02
Primary Completion
2020-03-31
Completion
2020-07-01

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03482674 on ClinicalTrials.gov